http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111700896-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
filingDate | 2020-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111700896-B |
titleOfInvention | Application of 3, 29-dibenzoyl trichosanthes seed triol in preparation of anti-esophageal cancer drugs |
abstract | The invention discloses application of 3, 29-dibenzoyl trichosanthes seed triol in preparation of an anti-esophageal cancer drug, wherein the 3, 29-dibenzoyl trichosanthes seed triol is separated from a trichosanthes extract. The snakegourd fruit is a plant fruit used as both medicine and food, has no toxicity and easily obtained raw materials, and experiments prove that the extracted compound 3, 29-dibenzoyl trichosanthes seed triol has a good effect of resisting esophageal cancer, which has not been reported before. |
priorityDate | 2020-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.